| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.13 | 3e-05 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.12 | 7e-05 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.0002 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | 0.17 | 0.0007 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0009 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.087 | 0.001 |